Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The time to offer treatments for COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory, et al.
Expert Opinion on Investigational Drugs (2021) Vol. 30, Iss. 5, pp. 505-518
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Secondary structural ensembles of the SARS-CoV-2 RNA genome in infected cells
Tammy C. T. Lan, Matthew F. Allan, Lauren E. Malsick, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 160
Therapeutics for COVID-19 and post COVID-19 complications: An update
Debdoot Basu, Vivek P. Chavda, Anita A. Mehta
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100086-100086
Open Access | Times Cited: 69
Third wave of COVID-19 in Madrid, Spain
Vincent Soriano, Carmen de Mendoza, Félix Gómez‐Gallego, et al.
International Journal of Infectious Diseases (2021) Vol. 107, pp. 212-214
Open Access | Times Cited: 47
Bacterial infections in patients hospitalized with COVID-19
Víctor Moreno‐Torres, Carmen de Mendoza, Sara de la Fuente, et al.
Internal and Emergency Medicine (2021) Vol. 17, Iss. 2, pp. 431-438
Open Access | Times Cited: 43
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
David Tak Wai Lui, Matthew S. H. Chung, Eric H. Y. Lau, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2314393-e2314393
Open Access | Times Cited: 18
From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114208-114208
Open Access | Times Cited: 17
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection
Vincent Soriano, Carmen de Mendoza, Benson Edagwa, et al.
Aids Reviews (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 23
A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors
David Tak Wai Lui, Kimberly Hang Tsoi, Chi‐Ho Lee, et al.
Endocrine (2023) Vol. 80, Iss. 2, pp. 380-391
Open Access | Times Cited: 14
Combination therapies for COVID‐19: An overview of the clinical trials landscape
Sola Akinbolade, Diarmuid Coughlan, Ross Fairbairn, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 4, pp. 1590-1597
Open Access | Times Cited: 31
Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
Gabriele Riccardi, Giovanni Francesco Niccolini, Mario Giuseppe Bellizzi, et al.
Diseases (2023) Vol. 11, Iss. 2, pp. 79-79
Open Access | Times Cited: 11
Investigating the trend of demographic changes, mortality, clinical and paraclinical findings of patients hospitalized in the Corona ward, before and after the start of general vaccination of COVID-19
Reza Morovatshoar, Kiavash Hushmandi, Sara Orouei, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
Jorge Calderón‐Parra, Valentín Cuervas‐Mons, Víctor Moreno‐Torres, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 51-58
Open Access | Times Cited: 21
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
Shunyao Chen, Cong Zhang, Deng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
On the implementation of a new version of the Weibull distribution and machine learning approach to model the COVID-19 data
Yinghui Zhou, Zubair Ahmad, Zahra Almaspoor, et al.
Mathematical Biosciences & Engineering (2022) Vol. 20, Iss. 1, pp. 337-364
Open Access | Times Cited: 12
The Value of Ursodeoxycholic Acid and Mesenchymal Stem Cells in the Treatment of Severe COVID-19
Qi Zheng, Yuetong Li, Guoping Sheng, et al.
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1269-1269
Open Access | Times Cited: 1
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Reviews in Medical Microbiology (2024)
Closed Access | Times Cited: 1
Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir
Ann‐Sofie Jemth, Emma Rose Scaletti, Evert Homan, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 8, pp. 102169-102169
Open Access | Times Cited: 6
A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19
Matrix Man Him Fung, David Tak Wai Lui, K.W. Chiu, et al.
PeerJ (2023) Vol. 11, pp. e15034-e15034
Open Access | Times Cited: 2
Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
Kunlakanya Jitobaom, Chompunuch Boonarkart, Suwimon Manopwisedjaroen, et al.
Acta Virologica (2023) Vol. 67
Open Access | Times Cited: 2
THE TIME COURSE OF THERAPEUTIC INTERVENTIONS FOR COVID-19
Binh Ngo, Paul E. Marik, Pierre Kory, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 5
The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors
David Tak Wai Lui, Ivan Fan‐Ngai Hung, Chi‐Ho Lee, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 5
A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection
David Tak Wai Lui, Chi‐Ho Lee, Ying Wong, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 4, pp. 763-770
Open Access
Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia
Yuhan Wang, Chung-Wei Lin, Chiung-Wei Huang
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2085-2085
Open Access
“A COMPREHENSIVE REVIEW OF THE INCREASE IN THYROID DISEASE CASES DUE TO THE COVID-19 PANDEMIC”
Drashti Desai
Journal of Population Therapeutics and Clinical Pharmacology (2024), pp. 1017-1025
Open Access
Page 1 - Next Page

Scroll to top